Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Docebo (DCBO) EBITDA (2019 - 2025)

Historic EBITDA for Docebo (DCBO) over the last 7 years, with Q3 2025 value amounting to $6.0 million.

  • Docebo's EBITDA rose 520.98% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 193.68%. This contributed to the annual value of $23.4 million for FY2024, which is 26205.72% up from last year.
  • As of Q3 2025, Docebo's EBITDA stood at $6.0 million, which was up 520.98% from $4.2 million recorded in Q2 2025.
  • Docebo's EBITDA's 5-year high stood at $9.2 million during Q4 2024, with a 5-year trough of -$1.6 million in Q4 2021.
  • Over the past 5 years, Docebo's median EBITDA value was $3.7 million (recorded in 2022), while the average stood at $3.2 million.
  • In the last 5 years, Docebo's EBITDA tumbled by 43523.21% in 2021 and then skyrocketed by 201070.11% in 2024.
  • Quarter analysis of 5 years shows Docebo's EBITDA stood at -$1.6 million in 2021, then surged by 260.42% to $2.5 million in 2022, then soared by 145.39% to $6.3 million in 2023, then soared by 46.51% to $9.2 million in 2024, then tumbled by 34.33% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $4.2 million for Q2 2025, and $1.5 million during Q1 2025.